Latest Breaking News On - Regina lutz - Page 1 : comparemela.com

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

JENA, Germany, May 21, 2024 InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American.

San diegoUnited statesInflarx gmbRegina lutzCamilla chongLaurie doyleJan medinaKatja arnoldGlobenewswire incInflarx pharmaceuticals incInflarx commitment programDrug administrationAmerican thoracic societyInternational conferenceEuropean medicines agencyMc services

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Chapel hillUnited statesMarcus maurerKatja arnoldChristopher sayedLaurie doyleRegina lutzJan medinaHarvard medical schoolUniversity of mainzAsthma european networksMc servicesEuropean medicines agencyInstitute of allergologyExchange commissionNational institutes of health

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkKatja arnoldJan medinaRegina lutzLaurie doyleMc servicesInflarx pharmaceuticals incDrug administrationInflarx commitment programEuropean medicines agencyCapital one securitiesBiopharma disrupters eventNew potential dermatology treatmentsInflarx pharmaceuticalsAnn arbor

InflaRx Appoints Jan Medina as Head of Investor Relations

InflaRx Appoints Jan Medina as Head of Investor Relations
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNielsc riedemannRegina lutzKatja arnoldLaurie doyleJan medinaExchange commissionInflarx pharmaceuticals incMc servicesTulane university school of engineeringDrug administrationEuropean medicines agencyInflarx commitment programVice presidentInvestor relationsChief executive officer

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible.

United statesLaurie doyleChristian sandrockRegina lutzNielsc riedemannInflarx gmbKatja arnoldExchange commissionInflarx commitment programCommitment programEuropean medicines agencyInflarx pharmaceuticals incCenters for diseaseUc davis healthMc servicesDrug administration